Catalyst Wire Dossier Catalyst Wire Dossier

Samelisant

SUVN-G3031 · Suven Life Sciences Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Samelisant, covering 2025-01-13 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy [Phase 3]

See pricing